Search - tctmd.com

Displaying 121 - 140 of 266

Sort: Relevancy | Date

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Presentation TCT 2014

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia

September 16, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

Presentation TCT 2014

Con: Ignore Aortic Regurgitation at Your Own Risk!

Presenter: Simon Redwood, Michael J. Mack

September 15, 2014

Presentation TCT 2014

Intraprocedural Assessment and Treatment of Paravalvular Regurgitation

Presenter: Sherif F. Nagueh, Neil J. Weissman, Stamatios Lerakis

September 15, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

Presentation TCT 2014

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Suzanne Baron

September 14, 2014

Presentation TCT 2014

TCT 664: Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Henrique B. Ribeiro

September 14, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR II: Will New TAVR Systems Eliminate the Problem?

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ian T. Meredith

September 14, 2014

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ronald M. Lazar

September 14, 2014

Presentation TCT 2014

Strokes After TAVR II: Management Considerations (Current and Future)

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Nicolas M. van Mieghem

September 14, 2014

Presentation TCT 2014

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

Presentation TCT 2014

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

Presenter: Markus Kasel, Joachim Schofer

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Daily News

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Yael L. Maxwell

September 02, 2014

Advertisement

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Views Differ on Future of Percutaneous Mitral Valve Therapies

Con: Ignore Aortic Regurgitation at Your Own Risk!

Intraprocedural Assessment and Treatment of Paravalvular Regurgitation

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

TCT 664: Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation

Paravalvular Regurgitation After TAVR II: Will New TAVR Systems Eliminate the Problem?

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Strokes After TAVR II: Management Considerations (Current and Future)

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

TCT Course Director Outlines Current TAVR Controversies

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content